Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (151-160 of 392) with videos related to

Pageof 40
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical TrialNorbert Stefan, Marek Hartleb, Jiangao Fan, et al.
Health and Quality of Life Outcomes|February 9, 2022
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosisMichael Nagel, Vanessa Weidner, Sina Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2016
Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogsChristopher P Regan, Gary L Stump, Theodore J Detwiler, et al.
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
Journal of the American College of Cardiology|September 14, 1999
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarctionJ J Lynch, G L Stump, A A Wallace, et al.
Digestive Diseases and Sciences|December 20, 2019
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)Leonard Kaps, Annette Grambihler, Bethlehem Yemane, et al.
Journal of the International AIDS Society|March 16, 2023
Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan AfricaRamiro Manzano-Nunez, Jesús Rivera-Esteban, Jordi Navarro, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Health-related quality of life in patients with autoimmune hepatitisMaurice Michel, Francesca Spinelli, Annette Grambihler, et al.
Journal of Hepatology|March 8, 2025
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosisA Zawadzki, D J Leeming, A J Sanyal, et al.
Pageof 40

Showing results (151-160 of 392) with videos related to

Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical TrialNorbert Stefan, Marek Hartleb, Jiangao Fan, et al.
Health and Quality of Life Outcomes|February 9, 2022
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosisMichael Nagel, Vanessa Weidner, Sina Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2016
Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogsChristopher P Regan, Gary L Stump, Theodore J Detwiler, et al.
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
Journal of the American College of Cardiology|September 14, 1999
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarctionJ J Lynch, G L Stump, A A Wallace, et al.
Digestive Diseases and Sciences|December 20, 2019
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)Leonard Kaps, Annette Grambihler, Bethlehem Yemane, et al.
Journal of the International AIDS Society|March 16, 2023
Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan AfricaRamiro Manzano-Nunez, Jesús Rivera-Esteban, Jordi Navarro, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Health-related quality of life in patients with autoimmune hepatitisMaurice Michel, Francesca Spinelli, Annette Grambihler, et al.
Journal of Hepatology|March 8, 2025
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosisA Zawadzki, D J Leeming, A J Sanyal, et al.
Pageof 40